{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:13:41Z","timestamp":1789586021924,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ejpb.2017.04.023","type":"journal-article","created":{"date-parts":[[2017,4,29]],"date-time":"2017-04-29T13:00:14Z","timestamp":1493470814000},"page":"308-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Solution or suspension \u2013 Does it matter for lipid based systems? In vivo studies of chase dosing lipid vehicles with aqueous suspensions of a poorly soluble drug"],"prefix":"10.1016","volume":"117","author":[{"given":"A.T.","family":"Larsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"M\u00fcllertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2017.04.023_b0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijpharm.2011.03.002","article-title":"In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems","volume":"417","author":"Larsen","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.04.023_b0010","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/j.2042-7158.2010.01107.x","article-title":"New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs","volume":"62","author":"M\u00fcllertz","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2017.04.023_b0015","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","article-title":"Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u2018self-microemulsifying\u2019 drug delivery systems","volume":"11","author":"Pouton","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2017.04.023_b0020","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1021\/bi00460a012","article-title":"Physical\u2013chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids","volume":"29","author":"Hernell","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejpb.2017.04.023_b0025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11095-008-9750-9","article-title":"Colloidal structures in media simulating intestinal fed state conditions with and without lipolysis products","volume":"26","author":"Fatouros","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2017.04.023_b0030","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s11095-005-8192-x","article-title":"The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids","volume":"22","author":"Persson","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2017.04.023_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0169-409X(91)90046-F","article-title":"Transport of lipophilic molecules by the intestinal lymphatic system","volume":"7","author":"Charman","year":"1991","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.ejpb.2017.04.023_b0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijpharm.2013.03.054","article-title":"Lipid-based formulations for oral administration of poorly water-soluble drugs","volume":"453","author":"Huiling","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.04.023_b0045","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/jps.2600620918","article-title":"Biopharmaceutics of drugs administered in lipid-containing dosage forms.1. GI-absorption of griseofulvin from an oil-in-water emulsion in rat","volume":"62","author":"Carrigan","year":"1973","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2017.04.023_b0050","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.2042-7158.1978.tb13247.x","article-title":"Bioavailability of phenytoin in lipid containing dosage forms in rats","volume":"30","author":"Chakrabarti","year":"1978","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2017.04.023_b0055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejpb.2007.01.017","article-title":"The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats","volume":"67","author":"Dahan","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.04.023_b0060","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s11095-008-9641-0","article-title":"Lipid-based formulations for danazol containing a digestible surfactant, Labrafil M2125CS: in vivo bioavailability and dynamic in vitro lipolysis","volume":"25","author":"Larsen","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2017.04.023_b0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","article-title":"Solubilizing excipients in oral and injectable formulations","volume":"21","author":"Strickley","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2017.04.023_b0070","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3109\/03639045.2011.645834","article-title":"In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life","volume":"38","author":"Arnold","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2017.04.023_b0075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijpharm.2005.05.011","article-title":"The development and characterisation of triglyceride-based \u2018spontaneous\u2019 multiple emulsions","volume":"300","author":"Devani","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.04.023_b0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejps.2016.01.011","article-title":"Effect of food intake and co-administration of placebo self-nanoemulsifying drug delivery systems on the absorption of cinnarizine in healthy human volunteers","volume":"84","author":"Christiansen","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2017.04.023_b0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: transport\/absorption\/elimination interplay and development of a biopharmaceutics drug disposition classification system","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2017.04.023_b0090","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/mp100049m","article-title":"Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media","volume":"7","author":"Fagerberg","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2017.04.023_b0095","doi-asserted-by":"crossref","unstructured":"H. T\u00f8nsberg, R. Holm, J.B. Boll, J. Jacobsen, A.M\u00fcllertz, Effects of polysorbate 80 on the in-vitro precipitation and oral bioavailability of halofantrine from polyethylene glycol 400 formulations in rats, J. Pharm. Pharmacol. 62(2\u201310), 63\u201370.","DOI":"10.1211\/jpp.62.01.0006"},{"key":"10.1016\/j.ejpb.2017.04.023_b0100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/jps.10045","article-title":"A physicochemical basis for the extensive intestinal lymphatic transport of a poorly lipid soluble antimalarial, halofantrine hydrochloride, after postprandial administration to dogs","volume":"91","author":"Khoo","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2017.04.023_b0105","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1248\/cpb.33.2069","article-title":"Kinetics of degradation of cinnarizine in aqueous-solution","volume":"33","author":"Tokumura","year":"1985","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2017.04.023_b0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jps.2600670137","article-title":"Determination of ionization-constants in mixed aqueous solvents of varying composition by a single titration","volume":"67","author":"Peeters","year":"1978","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2017.04.023_b0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0021-9673(93)87027-J","article-title":"Reversed-phase high-performance liquid-chromatography for evaluating the lipophilicity of pharmaceutical substances with ionization up tolLog Papp = 8","volume":"629","author":"Belsner","year":"1993","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.ejpb.2017.04.023_b0120","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1023\/A:1015877929381","article-title":"Solubilization and wetting effects of bile-salts on the dissolution of steroids","volume":"8","author":"Bakatselou","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2017.04.023_b0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0928-0987(99)00084-6","article-title":"Caffeine and nicotinamide enhances the aqueous solubility of the antimalarial agent halofantrine","volume":"10","author":"Lim","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2017.04.023_b0130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/pharmaceutics4040641","article-title":"SNEDDS containing poorly water soluble cinnarizine; development and in vitro characterization of dispersion, digestion and solubilization","volume":"4","author":"Larsen","year":"2012","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2017.04.023_b0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-5173(95)04214-8","article-title":"Characterization and bioavailability of danazol-hydroxypropyl beta-cyclodextrin coprecipitates","volume":"128","author":"Badawy","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.04.023_b0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0731-7085(95)01256-K","article-title":"Simplified liquid-chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions","volume":"13","author":"Humberstone","year":"1995","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2017.04.023_b0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejpb.2016.01.007","article-title":"Effect of cyclodextrin concentration on the oral bioavailability of danazol and cinnarizine in rats","volume":"101","author":"Holm","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.04.023_b0150","first-page":"G242","article-title":"Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats","volume":"255","author":"Raybould","year":"1988","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejpb.2017.04.023_b0155","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/js950472p","article-title":"A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine","volume":"85","author":"Humberstone","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2017.04.023_b0160","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/jps.22122","article-title":"Biorelevant media simulating fed state intestinal fluids: colloid phase characterization and impact on solubilization capacity","volume":"99","author":"Kleberg","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2017.04.023_b0165","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/B:PHAM.0000016282.77887.1f","article-title":"Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations","volume":"21","author":"Kaukonen","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2017.04.023_b0170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejps.2004.11.005","article-title":"Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug","volume":"24","author":"Sunesen","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2017.04.023_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0939-8600(02)80002-5","article-title":"The forestomach of rats and mice, an effective device supporting digestive metabolism in muridae","volume":"42","author":"G\u00e4rtner","year":"2001","journal-title":"J. Exp. Anim. Sci."},{"key":"10.1016\/j.ejpb.2017.04.023_b0180","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0041-008X(71)90103-7","article-title":"Mechanism of enhanced drug effects produced by dilution of the oral dose","volume":"19","author":"Borowitz","year":"1971","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejpb.2017.04.023_b0185","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/bdd.2510150508","article-title":"The effect of oral dose volume on the absorption of highly and poorly water soluble drug in the rat","volume":"15","author":"Nickerson","year":"1994","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejpb.2017.04.023_b0190","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0531-5565(96)00029-0","article-title":"Influence of aging on gastric emptying of liquids, small intestine transit, and fecal output in rats","volume":"31","author":"Smits","year":"1996","journal-title":"Exp. Gerontol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117300231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117300231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T10:30:11Z","timestamp":1569148211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641117300231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":38,"alternative-id":["S0939641117300231"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.04.023","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solution or suspension \u2013 Does it matter for lipid based systems? In vivo studies of chase dosing lipid vehicles with aqueous suspensions of a poorly soluble drug","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}